Skip to content
value.today

ATAI Life Sciences AG

🇩🇪 Munich, Germany, GermanyPharmaceuticalsFounded 2018
Total raised
$83 M
4 rounds on record
Latest round
$18 M
Nov 2020
First round on record
Oct 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ATAI Life Sciences AG
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2020$18 MNo. 4$10 to $50 million

ATAI Life Sciences AG: Raise no. 4, Nov 2020

Investors in this round

24 investors had bought by the notice of Dec 7, 2020: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $94 M offered; $75 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Germany

People named in the notice

  • Christian Angermayer · Executive Officer, Promoter · FOUNDER
  • Florian Brand · Executive Officer, Promoter · CO-FOUNDER AND CEO
  • Lars Wilde · Promoter · CO-FOUNDER
  • Srinivas Rao · Promoter · CO-FOUNDER

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Florian Brand, Co-founder and ceo. Source: SEC Form D, newest notice filed Dec 7, 2020. Read the notice at the SEC.

debt, optionsSEC
Jan 2020$11 MNo. 3$10 to $50 million

ATAI Life Sciences AG: Raise no. 3, Jan 2020

Investors in this round

32 investors had bought by the notice of Oct 20, 2020: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $33 M offered; $23 M still to sell
Smallest investment taken
$110,124
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Germany

People named in the notice

  • Florian Brand · Executive Officer, Promoter · CO-FOUNDER AND CEO
  • Christian Angermayer · Promoter · FOUNDER
  • Lars Wilde · Promoter · CO-FOUNDER
  • Srinivas Rao · Promoter · CO-FOUNDER

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Florian Brand, Co-founder and ceo. Source: SEC Form D and 1 amendment, newest notice filed Oct 20, 2020. Read the notice at the SEC.

debt, optionsSEC
Apr 2019$30 MNo. 2$10 to $50 million

ATAI Life Sciences AG: Raise no. 2, Apr 2019

Investors in this round

23 investors had bought by the notice of May 17, 2019: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $43 M offered; $13 M still to sell
Smallest investment taken
$111,628
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Germany

People named in the notice

  • Florian Brand · Executive Officer · CO-FOUNDER AND CEO
  • Christian Angermayer · Promoter · FOUNDER
  • Lars Wilde · Promoter · CO-FOUNDER

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Florian Brand, Co-founder & ceo. Source: SEC Form D, newest notice filed May 17, 2019. Read the notice at the SEC.

equitySEC
Oct 2018$23 MNo. 1$10 to $50 million

ATAI Life Sciences AG: Raise no. 1, Oct 2018

Investors in this round

8 investors had bought by the notice of May 17, 2019: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
$111,628
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Germany

People named in the notice

  • Florian Brand · Executive Officer · CO-FOUNDER AND CEO
  • Christian Angermayer · Promoter · FOUNDER
  • Lars Wilde · Promoter · CO-FOUNDER

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Florian Brand, Co-founder & ceo. Source: SEC Form D, newest notice filed May 17, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ATAI Life Sciences AG chose not to state its revenue in its newest notice of a funding round (Dec 2020).

    SEC Form D · Dec 2020

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2020

That is all the official record says: ATAI Life Sciences AG has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ATAI Life Sciences AG is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 32 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ATAI Life Sciences AG
NameRoleNamed in
Christian AngermayerFOUNDERDec 2020
Florian BrandCO-FOUNDER AND CEODec 2020
Christian AngermayerFOUNDERDec 2020
Florian BrandCO-FOUNDER AND CEODec 2020
Lars WildeCO-FOUNDERDec 2020
Srinivas RaoCO-FOUNDERDec 2020